Multiple Assemblies exist for SMTL entry 5skd
Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(2,5-difluorophenyl)pyrazol-3-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4-one; X-RAY DIFFRACTION 2.30 Å

	SMTL ID 5skd.1 Ligands ZINC ION; MAGNESIUM ION; 3-[1-(2,5-difluorophenyl)-1H-pyrazol-5-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4(1H)-one Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer
	SMTL ID 5skd.2 Ligands ZINC ION; MAGNESIUM ION; PRASEODYMIUM ION; GLYCEROL; 3-[1-(2,5-difluorophenyl)-1H-pyrazol-5-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4(1H)-one Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer
	SMTL ID 5skd.3 Ligands ZINC ION; MAGNESIUM ION; PRASEODYMIUM ION; 3-[1-(2,5-difluorophenyl)-1H-pyrazol-5-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4(1H)-one Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer
	SMTL ID 5skd.4 Ligands ZINC ION; MAGNESIUM ION; 3-[1-(2,5-difluorophenyl)-1H-pyrazol-5-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4(1H)-one Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer